Universidade de São Paulo, Faculdade de Medicina, Instituto do Câncer do Estado de São Paulo (ICESP), Serviço de Endoscopia, São Paulo, SP, Brasil.
Fleury Medicina e Saúde, São Paulo, SP, Brasil.
Arq Gastroenterol. 2021 Apr-Jun;58(2):210-213. doi: 10.1590/S0004-2803.202100000-37.
A common site of neuroendocrine tumors (NETs) is the rectum. The technique most often used is endoscopic mucosal resection with saline injection. However, deep margins are often difficult to obtain because submucosal invasion is common. Underwater endoscopic mucosal resection (UEMR) is a technique in which the bowel lumen is filled with water rather than air, precluding the need for submucosal lifting.
This study aimed to evaluate the efficacy and safety of UEMR for removing small rectal neuroendocrine tumors (rNETs).
Retrospective study with patients who underwent UEMR in two centers. UEMR was performed using a standard colonoscope. No submucosal injection was performed. Board-certified pathologists conducted histopathologic assessment.
UEMR for small rNET was performed on 11 patients (nine female) with a mean age of 55.8 years and 11 lesions (mean size 7 mm, range 3-12 mm). There were 9 (81%) patients with G1 rNET and two patients with G2, and all tumors invaded the submucosa with only one restricted to the mucosa. None case showed vascular or perineural invasion. All lesions were removed en bloc. Nine (81%) resections had free margins. Two patients had deep margin involvement; one had negative biopsies via endoscopic surveillance, and the other was lost to follow-up. No perforations or delayed bleeding occurred.
UEMR appeared to be an effective and safe alternative for treatment of small rNETs without adverse events and with high en bloc and R0 resection rates. Further prospective studies are needed to compare available endoscopic interventions and to elucidate the most appropriate endoscopic technique for resection of rNETs.
神经内分泌肿瘤(NETs)的常见部位是直肠。最常使用的技术是内镜黏膜下切除术联合盐水注射。然而,由于黏膜下浸润很常见,深部切缘往往难以获得。水下内镜黏膜切除术(UEMR)是一种在肠腔内充满水而不是空气的技术,从而无需进行黏膜下抬举。
本研究旨在评估 UEMR 切除小直肠神经内分泌肿瘤(rNET)的疗效和安全性。
对两家中心接受 UEMR 的患者进行回顾性研究。UEMR 使用标准结肠镜进行。未进行黏膜下注射。由经过委员会认证的病理学家进行组织病理学评估。
UEMR 用于 11 名(9 名女性)平均年龄为 55.8 岁的患者的小 rNET,共 11 个病变(平均大小为 7mm,范围 3-12mm)。9 例(81%)为 G1 rNET,2 例为 G2,所有肿瘤均侵犯黏膜下层,仅 1 例局限于黏膜层。无一例出现血管或神经周围侵犯。所有病变均整块切除。9 例(81%)切除标本边缘无肿瘤。2 例有深部切缘受累;1 例经内镜监测活检阴性,另 1 例失访。无穿孔或延迟性出血发生。
UEMR 似乎是一种有效且安全的替代治疗方法,用于治疗小 rNET,无不良事件,整块和 R0 切除率高。需要进一步的前瞻性研究来比较现有的内镜干预措施,并阐明最适合切除 rNET 的内镜技术。